Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 2/2003

01-02-2003

Deoxycoformycin-Containing Combination Chemotherapy for Adult T-Cell Leukemia-Lymphoma: Japan Clinical Oncology Group Study (JCOG9109)

Authors: Kunihiro Tsukasaki, Kensci Tobinai, Masanori Shimoyama, Mitsuo Kozuru, Naokuni Uikc, Yasuaki Yamada, Masao Tomonaga, Koichi Araki, Masaharu Kasai, Kiyoshi Takatsuki, Mitsutoshi Tara, Chikara Mikuni, Tomomitsu Hotta, Members of the Lymphoma Study Group (LSG) of the Japan Clinical Oncology Group (JCOG)

Published in: International Journal of Hematology | Issue 2/2003

Login to get access
Metadata
Title
Deoxycoformycin-Containing Combination Chemotherapy for Adult T-Cell Leukemia-Lymphoma: Japan Clinical Oncology Group Study (JCOG9109)
Authors
Kunihiro Tsukasaki
Kensci Tobinai
Masanori Shimoyama
Mitsuo Kozuru
Naokuni Uikc
Yasuaki Yamada
Masao Tomonaga
Koichi Araki
Masaharu Kasai
Kiyoshi Takatsuki
Mitsutoshi Tara
Chikara Mikuni
Tomomitsu Hotta
Members of the Lymphoma Study Group (LSG) of the Japan Clinical Oncology Group (JCOG)
Publication date
01-02-2003
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 2/2003
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/BF02983215

Other articles of this Issue 2/2003

International Journal of Hematology 2/2003 Go to the issue

Letter to the Editor

Gray Platelet Syndrome Presenting As Menorrhagia

OriginalPaper

Proliferation of Human Progenitor Cells in a Long-term Culture System is More Efficiently Sustained by the Addition of Flt-3 Ligand or Megakaryocyte Growth and Development Factor than by Kit Ligand

Letter to the Editor

Kawasaki Disease in a Patient with Wiskott-Aldrich Syndrome: An Increase in the Platelet Count

Case Report

Pyomyositis as a Focus of Infection in Hematological Disorders: A Report of 3 Cases

OriginalPaper

Pathogenesis of Selective Expansion of PNH Clones

OriginalPaper

Management Issues in Paroxysmal Nocturnal Hemoglobinuria
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits